Target intelligence / Profile preview

Bile acids (BA) (BA)

Target
BA
Molecular classification
Other
01

Overview

Bile acids are amphipathic steroid molecules synthesized from cholesterol in the liver and secreted into the gastrointestinal lumen to facilitate the digestion and absorption of dietary fats and fat-soluble vitamins. In the gut, they act as detergents to emulsify lipids and also serve as important signaling molecules that regulate metabolic processes through the activation of receptors like the farnesoid X receptor (FXR) and TGR5 (Nature Reviews Gastroenterology & Hepatology, 10.1038/nrgastro.2017.132). As a therapeutic target, bile acids in the gastrointestinal lumen are bound by non-absorbable resins known as bile acid sequestrants. This binding prevents their enterohepatic recirculation, leading to increased hepatic synthesis of bile acids from cholesterol and a subsequent reduction in serum LDL cholesterol levels (StatPearls, NBK526095). Additionally, targeting the bile acid pool is essential in managing bile acid malabsorption, which causes chronic diarrhea, and in alleviating pruritus associated with cholestatic liver diseases. The modulation of bile acid concentrations in the lumen also influences the gut microbiome and systemic metabolic health (PubMed, 28848233).

Other names
Bile saltsIntestinal bile acidsPrimary bile acidsSecondary bile acidsSteroid acids
02

Mechanism of action

Bile acid sequestrants are non-absorbable anion-exchange resins that bind to negatively charged bile acids in the gastrointestinal lumen, forming insoluble complexes that are excreted in the feces and preventing their enterohepatic recirculation (StatPearls, NBK526095).

03

Biological functions

Signal transductionOther
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Gastrointestinal distress (constipation, flatulence, bloating)Malabsorption of fat-soluble vitamins (A, D, E, K)Interference with the absorption of co-administered oral medications
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

7α-hydroxy-4-cholesten-3-one (C4)Fibroblast growth factor 19 (FGF19)Total fecal bile acids

Beyond the preview

Go deeper on Bile acids (BA) (BA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acids (BA) (BA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call